Using some naive assumptions here (that the average weight loss required for the average obese persons BMI to be below 30 and thus not categorized as obese, assuming x% of obese people take the drug and all experience the average reduction in body weight), we can see a picture emerge that shows the potential to disrupt a trend thats been forming for the past 50 years
Costa TA, Harrington JL (2025) Advances in the management of obesity and heart failure: latest evidence from clinical trials
A.AzamK.EskandariM
For instance, the sale of La Ligas Atltico de Madrid to Apollo Sports Capital, which closed in March and was priced at roughly $2.95 billion at the current exchange rate, including debt, came at about six times the teams revenue the previous season
GLP-1 medications are prescription drugs that require evaluation by a licensed healthcare provider
Trends in Cardiovascular Medicine, 33 (3), 159166